Eagle Bay Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eagle Bay Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$68,976
+30.9%
770
+24.4%
0.03%
+6.7%
Q2 2023$52,702
-6.1%
619
-8.7%
0.03%
-3.2%
Q1 2023$56,105
-9.9%
678
-14.4%
0.03%
-11.4%
Q4 2022$62,291
+29.8%
792
+23.6%
0.04%
+16.7%
Q3 2022$48,000
-99.9%
641
-1.8%
0.03%
+15.4%
Q2 2022$42,563,000
+265918.8%
653
+155.1%
0.03%
+100.0%
Q1 2022$16,000
-11.1%
256
-20.5%
0.01%
+18.2%
Q4 2021$18,000
+5.9%
322
+29.8%
0.01%
+10.0%
Q3 2021$17,000
-5.6%
248
+0.8%
0.01%
-28.6%
Q2 2021$18,0002460.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders